The gold standard for arthritis is an antimetabolite with many faces

Methotrexate - Pharmacology (DMARDs, mechanism of action, side effects) · 6:25 · Video: Armando Hasudungan · Watch at the source

In short: Methotrexate is a cornerstone of modern rheumatology, yet its complexity is often understated. While it is primarily known for managing autoimmune conditions, it functions through a sophisticated web of biological pathways, acting as an antimetabolite that can simultaneously slow cell growth and dampen systemic inflammation.

Despite the emergence of modern biologic agents, low-dose methotrexate remains the primary first-line treatment for rheumatoid arthritis (RA) and psoriatic arthritis. It is frequently used to bolster the effectiveness of these newer biologics. As an antimetabolite, it works by interfering with the metabolic processes of cells. In the context of psoriasis, it slows the rapid growth of skin cells, while in oncology, it functions by inhibiting the proliferation of cancer cells.

The drug's pharmacological profile is notably diverse. Rather than relying on a single pathway, methotrexate influences several distinct mechanisms to suppress inflammation. It can inhibit the synthesis of purines and pyrimidines, interfere with transmethylation reactions, and impact nitric oxide production. Furthermore, it modulates complex signaling pathways, including the movement of nuclear factor-κB (NF-κB) into the nucleus and the signaling involving the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) proteins. It also promotes the release of adenosine and influences the expression of specific long non-coding RNAs.

Precision in dosing is critical for patient safety. For autoimmune conditions, the medication is typically administered once a week—either as a single dose or split into three doses spaced 12 hours apart. It is never taken daily for these conditions, as overdosage can lead to severe toxicity, including liver damage and bone marrow suppression. Because of these risks, clinicians emphasize strict adherence to the prescribed schedule to balance its therapeutic benefits against its potential for serious harm.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-methotrexate-pharmacology-dmards-mechanism-of-action-side-ef.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…